These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6089761)

  • 1. Vasopressin and angiotensin control the activity of liver phosphodiesterase.
    Keppens S; De Wulf H
    Biochem J; 1984 Aug; 222(1):277-80. PubMed ID: 6089761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of calcium as second messenger in liver for the hormonally induced activation of glycogen phosphorylase.
    Keppens S; Vandenheede JR; De Wulf H
    Biochim Biophys Acta; 1977 Feb; 496(2):448-57. PubMed ID: 189844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the desensitization and resensitization of the cyclic AMP-independent glycogenolytic response in rat liver cells.
    Keppens S; De Wulf H
    Biochem J; 1982 Nov; 208(2):317-22. PubMed ID: 6297467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2-purinergic control of liver glycogenolysis.
    Keppens S; De Wulf H
    Biochem J; 1985 Nov; 231(3):797-99. PubMed ID: 3000360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of calcium ion as a mediator of the effects of angiotensin II, catecholamines, and vasopressin on the phosphorylation and activity of enzymes in isolated hepatocytes.
    Garrison JC; Borland MK; Florio VA; Twible DA
    J Biol Chem; 1979 Aug; 254(15):7147-56. PubMed ID: 222757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of glycogenolysis against hormones in isolated rat hepatocytes].
    Chen W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):123-7. PubMed ID: 8242820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of a plasma membrane phosphodiesterase in the negative control of cyclic AMP levels by vasopressin in rat hepatocytes.
    Miot F; Keppens S; Erneux C; Wells JN; De Wulf H
    Biochem Pharmacol; 1988 Sep; 37(18):3447-53. PubMed ID: 2844189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II inhibits hepatic cAMP accumulation induced by glucagon and epinephrine and their metabolic effects.
    Morgan NG; Exton JH; Blackmore PF
    FEBS Lett; 1983 Mar; 153(1):77-80. PubMed ID: 6298010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glucagon, dibutyryl adenosine 3',5'-cyclic monophosphate and phosphodiesterase inhibitors on rat liver phosphorylase activity and adenosine 3',5'-cyclic monophosphate levels.
    Ingebretsen C; Clark JF; Allen DO; Ashmore J
    Biochem Pharmacol; 1974 Aug; 23(15):2139-46. PubMed ID: 4369954
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of glycogen phosphorylase activity in isolated human hepatocytes.
    Keppens S; Vandekerckhove A; Moshage H; Yap SH; Aerts R; De Wulf H
    Hepatology; 1993 Apr; 17(4):610-4. PubMed ID: 8386694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effect of glucagon on 3', 5'-cyclic AMP phosphodiesterase activity in isolated rat hepatocytes.
    Allan EH; Sneyd JG
    Biochem Biophys Res Commun; 1975 Feb; 62(3):594-601. PubMed ID: 164185
    [No Abstract]   [Full Text] [Related]  

  • 12. cAMP-independent stimulation of glycogen phosphorylase in newborn rat hepatocytes.
    Noguchi A; Jett PA; Gold AH
    Am J Physiol; 1985 May; 248(5 Pt 1):E560-6. PubMed ID: 2986465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid stimulation by vasopressin, oxytocin and angiotensin II of glycogen degradation in hepatocyte suspensions.
    Hems DA; Rodrigues LM; Whitton PD
    Biochem J; 1978 May; 172(2):311-7. PubMed ID: 666748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in the mechanism of action of alpha-adrenergic agonists and vasopressin or angiotensin II in stimulating hepatic glycogenolysis; a role of extracellular calcium concentration.
    Koide Y; Kimura S; Kugai N; Demura N; Yamashita K
    Endocrinol Jpn; 1985 Feb; 32(1):103-12. PubMed ID: 4017969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of glycogen synthase and phosphorylase in hepatocytes from diabetic rats. Effects of glucagon, vasopressin, and vanadate.
    Rodríguez-Gil JE; Gómez-Foix AM; Ariño J; Guinovart JJ; Bosch F
    Diabetes; 1989 Jun; 38(6):793-8. PubMed ID: 2498142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of liver cells formed after partial hepatectomy to glucagon, vasopressin and angiotensin II.
    Huerta-Bahena J; Villalobos-Molina R; Corvera S; García-Saínz JA
    Biochim Biophys Acta; 1983 Sep; 763(2):120-4. PubMed ID: 6311282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic stimulation of Ca2+ uptake by glucagon and Ca2+-mobilizing hormones in the perfused rat liver. A role for mitochondria in long-term Ca2+ homoeostasis.
    Altin JG; Bygrave FL
    Biochem J; 1986 Sep; 238(3):653-61. PubMed ID: 3026358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-promoting effects of Ca(2+)-mobilizing agents in hepatocytes: lack of correlation between the acute activation of phosphoinositide-specific phospholipase C and the stimulation of DNA synthesis by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2 alpha.
    Dajani OF; Røttingen JA; Sandnes D; Horn RS; Refsnes M; Thoresen GH; Iversen JG; Christoffersen T
    J Cell Physiol; 1996 Sep; 168(3):608-17. PubMed ID: 8816915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal control of pyruvate dehydrogenase activity in rat liver.
    Oviasu OA; Whitton PD
    Biochem J; 1984 Nov; 224(1):181-6. PubMed ID: 6391471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II.
    Hems DA; Rodrigues LM; Whitton PD
    Biochem J; 1976 Nov; 160(2):367-74. PubMed ID: 827289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.